سرمایه گذاری شفا دارو
شفا | Stocks - Tehran Stock Exchange (TSE)
سایر محصولات دارویی
Sector:
سایر محصولات دارویی
Market Type:
Stocks
Status:
Authorized
Last Price: 80,330 0.30
Close Price: 81,110
Cash Flow
AGM
Interim
2026/05/05 Fiscal Year 2025/12/2112 Month / Audited | 2026/04/20 Fiscal Year 2025/12/2112 Month | ||
|---|---|---|---|
Cash Generated from Operations | 734.483 Billion | 71.924 Billion | |
Income Taxes Paid | -3.531 Billion | - | |
Net Cash Flow from Operating Activities | 730.952 Billion | 71.924 Billion | |
Proceeds from Sale of Property, Plant and Equipment | 84.907 Billion | - | |
Purchases of Property, Plant and Equipment | -3.253 Billion | -3.253 Billion | |
Purchases of Intangible Assets | -7.442 Billion | - | |
Cash Paid to Acquire Long-Term Investments | -18.766 Billion | - | |
Cash Received from Income on Other Investments | 132.958 Billion | - | |
Net Cash Flow from Investing Activities | 110.939 Billion | -3.253 Billion | |
Net Cash Flow before Financing Activities | 841.891 Billion | 841.891 Billion | |
Cash Received from Borrowings | 56.967 Trillion | - | |
Repayments of Borrowings (Principal) | -50.637 Trillion | - | |
Interest Paid on Borrowings | -7.458 Trillion | - | |
دریافت های نقدی حاصل از انتشار اوراق خرید دین | 28.155 Trillion | - | |
پرداخت های نقدی بابت اصل اوراق خرید دین | -28.081 Trillion | - | |
Interest Paid on Debt Purchase Instruments | -2.943 Trillion | - | |
Dividends Paid | -745.653 Billion | -745.653 Billion | |
Dividends Paid to Non-Controlling Interests | -3.284 Trillion | - | |
Net Cash Flow from Financing Activities | -745.653 Billion | -22.396 Billion | |
Net Increase (Decrease) in Cash | 96.238 Billion | 49.528 Billion | |
Cash at Beginning of Period | 808.894 Billion | 907.582 Billion | |
Effect of Exchange Rate Changes | 2.45 Billion | 2.45 Billion | |
Cash at End of Period | 811.344 Billion | 811.344 Billion | |
Non-Cash Transactions | 4.683 Trillion | 4.683 Trillion |